Faron Pharmaceuticals Oy Share Discussion Threads

[x54v] 19/9/2017 14:36

Some dip buying today taking the price back up.

The latest £456k purchase by Jonathan Knowles really dwarfs his previous buys. He must be very confident indeed to want to buy quite so much stock.

[x54v] 13/9/2017 12:37

Faron Pharma primed for a pivotal period in its development

[x54v] 13/9/2017 12:36

Faron Pharmaceuticals boss upbeat as Phase III trial enters critical period

[x54v] 13/9/2017 11:47

Good breakout here today after a multi-month consolidation.

One of the directors clearly very keen on the shares buying a £456,750 worth of stock a couple of days ago. Quite a considerable purchase.

[11_percent] 04/9/2017 08:36

Good news.

[jamesd888] 10/5/2017 12:24

Good to see this on the move back towards 800p today

[jamesd888] 09/5/2017 08:42

See this moving too new highs

[jamesd888] 08/5/2017 14:08

probably close around 700p today

[jamesd888] 08/5/2017 14:08

Today's RNS were good news and share price drops might be a good opp to buy now.

[jamesd888] 08/5/2017 13:41

The independent data monitoring committee has now reviewed the trial data four times
picture of drugs in trial
Up to 300 ARDS patients will take part in the trial
Faron Pharmaceuticals Ltd's (LON: FARN) has received another recommendation that its ongoing INTEREST trial for lead drug Traumakine can continue as planned with no changes.

The independent data monitoring committee has now reviewed the trial data four times with the next scheduled review at 240 recruited patients and likely to be in the third quarter of 2017.

INTEREST is a Phase III double-blind, randomised, parallel-group comparison of the efficacy and safety of Traumakine in patients suffering with moderate to severe ARDS, an often fatal orphan disease with a mortality rate of approximately 30-45%.

CLICK HERE: For a daily round-up of all the Proactive news

The study, designed to include up to 300 patients, is currently being conducted in 60 hospital intensive care units (ICU) in Belgium, Finland, France, Germany, Italy, Spain and UK.

The INTEREST trial protocol is targeting a 50% reduction in all cause mortality at day 28 between placebo and treatment arm (from 30% to 15%).

Dr Markku Jalkanen, Faron’s chief executive said: "We were again very delighted to learn that the IDMC gave us another recommendation to continue the INTEREST study as planned.

“We are looking forward to their next recommendation in Q3 2017, which we hope to confirm our plans for the future of the product and for ARDS patients."

There is no treatment for ARDS currently, which is often linked to pneumonia and characterised by widespread capillary leakage and inflammation in the lungs.

[rizler] 10/4/2017 12:19

Ooo do we think this is the top for now?

[saturn5] 06/4/2017 20:58

My gut feeling is big things to come

Keep watching BOO because its cheaper but good

JOG is another with good prospects

All the best

[lauders] 05/4/2017 01:40

Saturn5 - Wondered what you were on about LOL! Then I looked at my post again and realized my iphone or "brain" must have been playing tricks on me when I typed the message as it was rather misleading. I have corrected it. So unfortunately I am not in but have been watching FARN go up and up :-( Well done for managing to get in lower than it is now.

[saturn5] 04/4/2017 19:08

I thin ph3 will go ok

This is proving to be one of my best shares

BOO is also doing well.

I will report on my 0ther winners later this week

[longshanks] 04/4/2017 12:27

I too am overwhelmed by the way this has risen in such a short space of time. Truth is though that they have a great drug candidate to satisfy a large unmet need so should see rapid commercialisation assuming the Ph3 goes to plan.I see no point in selling yet. Could easily see £10 this year.

[saturn5] 02/4/2017 10:34

Lauders

You were very lucky

Could be very good this year

[lauders] 15/3/2017 09:37

Most are probably amazed at the rise and too stunned comment! Wish I had purchased at 250p just a short time ago!

[capt bligh] 14/3/2017 17:46

Not much comment here... considering the rocket.

[capt bligh] 14/3/2017 17:45

Not much comment here... considering the rocket.

[lauders] 02/3/2017 08:50

Many thanks capt bligh! Much better. Pretty impressive chart at the moment!

[lauders] 01/3/2017 15:18

Any chance of some charts here capt bligh? Please :-) Interested in following FARN too.

[capt bligh] 28/2/2017 08:41

interesting rns